Professor Katie Doores
Professor of Viral Immunology
- School Academic Lead, Postgraduate Research
Research interests
- Immunology
Biography
Katie received her PhD in Organic Chemistry from the University of Oxford in 2008 studying carbohydrate chemistry. She then moved to The Scripps Research Institute, California for her postdoctoral studies to work with Dennis Burton where she studied HIV glycobiology and HIV broadly neutralizing antibodies. In June 2013, Katie was awarded an MRC Career Development Award and moved to King’s College London to start her research lab.
In 2017 Katie was selected as a member of the EMBO Young Investigator Programme. Katie was awarded the Medical Research Foundation Emerging Leaders Prize for COVID-19 (2021). In 2023, Katie was named as the Biological Sciences Laureate at the Blavatnik Awards for young scientists in the UK.
The publication feed is not currently available.
Research
Doores Lab
The Doores Lab is in the Department of Infectious Diseases
Microbes in Health & Disease
The Microbes in Health & Diseases Research Interest Group aims to foster collaboration across departments and faculties at KCL to explore the multifaceted role microbes play in health and disease.
News
Dr Katie Doores receives esteemed Blavatnik Award for Young Scientists
Katie is one of three Blavatnik Laureates, winning the Life Sciences category for her research which aims to improve our preparedness for future pandemics.
King's study provides vital information to guide COVID-19 vaccine development
The researchers examined antibodies from people who had recovered from COVID-19 in multiple countries.
Dr Katie Doores wins prize for outstanding COVID-19 research
Dr Katie Doores has been named as one of the winners of the Medical Research Foundation’s 2021 Emerging Leaders Prize.
COVID-19 antibodies remain in the body 10 months after infection
The study, published in Nature Microbiology, looked at the antibodies of 38 patients and healthcare workers in St Thomas’ Hospital who were infected within...
Exposure to SARS-CoV-2 during pregnancy impacts the developing immune system of the fetus
New research from King’s suggests COVID-19 infection in the mother alters the immune system of the baby in utero.
Scientists uncover a molecule that can help coronavirus escape antibodies
A natural molecule can effectively block the binding of a subset of human antibodies to SARS-CoV-2, researchers have found.
Covid-19 antibodies can decline over time, research suggests
Antibody responses to SARS-CoV-2 can peak three weeks post onset of symptoms but begin to decline after as little as 2-3 months, according to research by...
The publication feed is not currently available.
Research
Doores Lab
The Doores Lab is in the Department of Infectious Diseases
Microbes in Health & Disease
The Microbes in Health & Diseases Research Interest Group aims to foster collaboration across departments and faculties at KCL to explore the multifaceted role microbes play in health and disease.
News
Dr Katie Doores receives esteemed Blavatnik Award for Young Scientists
Katie is one of three Blavatnik Laureates, winning the Life Sciences category for her research which aims to improve our preparedness for future pandemics.
King's study provides vital information to guide COVID-19 vaccine development
The researchers examined antibodies from people who had recovered from COVID-19 in multiple countries.
Dr Katie Doores wins prize for outstanding COVID-19 research
Dr Katie Doores has been named as one of the winners of the Medical Research Foundation’s 2021 Emerging Leaders Prize.
COVID-19 antibodies remain in the body 10 months after infection
The study, published in Nature Microbiology, looked at the antibodies of 38 patients and healthcare workers in St Thomas’ Hospital who were infected within...
Exposure to SARS-CoV-2 during pregnancy impacts the developing immune system of the fetus
New research from King’s suggests COVID-19 infection in the mother alters the immune system of the baby in utero.
Scientists uncover a molecule that can help coronavirus escape antibodies
A natural molecule can effectively block the binding of a subset of human antibodies to SARS-CoV-2, researchers have found.
Covid-19 antibodies can decline over time, research suggests
Antibody responses to SARS-CoV-2 can peak three weeks post onset of symptoms but begin to decline after as little as 2-3 months, according to research by...